John H. Eldridge
Chief Tech/Sci/R&D Officer at Profectus BioSciences, Inc.
Profile
John H.
Eldridge is currently the Chief Scientific Officer-Vaccines at Profectus BioSciences, Inc. He previously worked as the Vice President-Advanced Vaccines Research at Wyeth LLC.
Prior to that, he was a Faculty Member at The University of Alabama.
Eldridge earned his doctorate degree from the State University of New York at Buffalo in 1981.
John H. Eldridge active positions
Companies | Position | Start |
---|---|---|
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Chief Tech/Sci/R&D Officer | 01/09/2008 |
Former positions of John H. Eldridge
Companies | Position | End |
---|---|---|
The University of Alabama | Corporate Officer/Principal | 01/01/1993 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Training of John H. Eldridge
State University of New York at Buffalo | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Profectus BioSciences, Inc.
Profectus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Profectus BioSciences, Inc. engages in the design and development of preventive and therapeutic vaccines. It develops novel vaccines for the prevention and treatment of infectious diseases and related cancers. The company’s vaccines are based on its proprietary VesiculoVax and GeneVax vaccine delivery platforms. The company was founded by Robert Charles Gallo, William A. Blattner, and Robert R. Redfield in 2003 and is headquartered in Baltimore, MD. | Health Technology |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
- Stock Market
- Insiders
- John H. Eldridge